SO YOU THINK CONTROL OF EARTH ORBIT IS UNIMPORTANT !!! USA in danger!!!!

Better read up on subject, while we have dismantled our capability & other space powers most not our friends are increasing their capabilities.

We have no leadership to keep us competitive with our adversaries !


But not many seem very concerned, but the USA is in danger!!!

Sent from my iPad

USA must have this capability! Set up blogs & contact media -EVERYBODY !!!

THE PEOPLE in charge are not Protecting this country---SPACE Capabilities one example!

We have many expensive & important systems in earth orbit AND we now need & will in the future the shuttle equivalent capabilities. Failing to maintain our capabilities will have disastrous results! Better pay attention!!!

We have the x37 that Boeing proposed to modify ( x37C) to be a shuttle equivalent.
However, the present leaders do not desire a STRONG America, rather they want a damaged, weak America!!

All you have to do is look at energy, borders, communicable diseases, space capabilities budget deficit. AND the media is not reporting the real situation to the public.

In order to save this country, we better get the public to be more aware of the present problems!

It is absolute insanity not to maintain space capabilities!!!

We threw away 1/3 trillion we had in shuttle.

Now we pay Russia --- bankrolling their program.

Will not use Boeing x37C.

Better get someone in charge!!!!!

Sent from my iPad

Now we have NOTHING!!!!!! Great management haha!

Spent 200 billion on shuttle over 30 years----in museum

Spent over 1 trillion on Iraq over ten years------Isis in town

A few other areas---

Welfare
Gainfully employed people
Borders
Diseases
Deficit spending

Fwd: X-37B space plane returns after 2-year mission

Sent from my iPad

Begin forwarded message:

From: "Gary Johnson" <gjohnson144@comcast.net>
Date: October 15, 2014 9:24:54 AM CDT
To: "Gary Johnson" <gjohnson144@comcast.net>
Subject: FW: X-37B space plane returns after 2-year mission

 

 

 

Air Force's X-37B space plane returns after 2-year top-secret mission

It's assumed that the X-37B -- one of two used by the military -- operates a lot like a spy satellite, only more versatile.

 

By Brooks Hays   |   Oct. 14, 2014 at 1:34 AM   |  

 

LOMPOC, Calif., Oct. 13 (UPI) -- The X-37B is coming home, presumably chock-full of secrets. The unmanned Air Force plane -- a sort of space drone that has spent the last two years orbiting the planet -- is expected to return to Earth on Tuesday. At some point during daylight hours, depending on weather, the plane will land at Vandenberg Air Force Base in California.

"Team Vandenberg stands ready to implement safe landing operations for the X-37B Orbital Test Vehicle, the third time for this unique mission" the Air Force's Col. Keith Baits, 30th Space Wing commander, said in a press release issued last week.

The Air Force's announcement of the plane's return landing arrived with few details, and that's been the case throughout the project's brief history. It's the plane's third complete mission since it first launched in 2010, the longest yet -- a world record at 671 days in space. And as was the case with the first and second missions, no one really knows what exactly the plane's been up to for the past two years.

It's assumed that the X-37B -- one of two used by the military -- operates a lot like a spy satellite, only more versatile. Military satellites are set up for a mission, blasted into space, and left un-tinkered-with for the rest of their lifetime. But because the X-37B is a plane, and can come and go as it pleases, it can be outfitted with a different array of sensors and instruments to complete the top-secret objectives of each new operation.

As is often the case for secretive government programs, the void left by the absence of official information is quickly filled by outlandish conspiracy theories. Some have speculated that the plane is used to listen in on other nation's spy and telecommunications satellites -- a task that hardly requires a next-generation space plane. Others suggest the drone is designed to physically assault or hijack other spy satellites. And a few have pegged the X-37B as the military's first space bomber, capable of dispensing and targeting a missile to anywhere on Earth within an hour's time. Such guesses range from ridiculous to unlikely, experts say.

"I think it is primarily an ISR (Intelligence, Surveillance and Reconnaissance) platform for testing new sensor technologies or validating new technologies," Brian Weeden, a retired U.S. Air Force Space Command officer, told The Daily Beast. "The current [vehicle] on orbit has basically been in the same orbit since launch, with only the occasional maneuver to maintain that orbit. That's consistent with a remote sensing/ISR mission."

Given that the X-37B's orbit passes atop North Korea, Iran, Pakistan, Afghanistan, and China, Weeden's explanation seems the most plausible.               

© 2014 United Press International, Inc. All Rights Reserved. 

 

---

 

 

Fwd: Rare Genetic Disease Protects Against Bipolar Disorder; Combating Bladder Cancer With Approved Drug

Sent from my iPad

Begin forwarded message:

From: Kent Castle <kent.d.castle@hotmail.com>
Date: October 14, 2014 4:55:46 PM CDT
To: Choban Peter <peter.s.choban@aero.org>, Reason Marilou <loganlou55@yahoo.com>, Astrology Valkyrie <astrogoddess@valkyrieastrology.com>, Patterson James <w8ljz@aol.com>, Martin Bobby <bobbygmartin1938@gmail.com>, Chamberlain Sharon <sharon.m.chamberlain@saic.com>, Carman Gilbert <gil77546@sbcglobal.net>, Schwering Suanne <suannesch@mac.com>, Sutherland Aurora <fuentesd11@yahoo.com>, Bentz Jerry <bentz@sbcglobal.net>, Arnold Jenny <arnoldrj@bellsouth.net>, Brown Paul <paul.brown1@yahoo.com>, Grant Berl <berlgrant@frontier.com>, Bilger Boyd <boyd.bilger@embarqmail.com>, Books Mark <mebooks2012@gmail.com>, Lozano Marianne <kemahsabe@comcast.net>, "lrodriguez@neighborhood-centers.org" <lrodriguez@neighborhood-centers.org>
Subject: FW: Rare Genetic Disease Protects Against Bipolar Disorder; Combating Bladder Cancer With Approved Drug

 

---

From: reply@mail.dddmag.com
To: KENT.D.CASTLE@HOTMAIL.COM
Subject: Rare Genetic Disease Protects Against Bipolar Disorder; Combating Bladder Cancer With Approved Drug
Date: Tue, 14 Oct 2014 13:01:27 -0600

Astellas Collaborates with Harvard for Retinal Degeneration Treatment; Rats of New York and The Diseases They Carry

View this email in your browser. OCT 14 IN THIS ISSUE   NEWS     Combating Bladder Cancer With Approved Drug     NEWS     Astellas Collaborates with Harvard for Retinal Degeneration Treatment     NEWS     Rats of New York and The Diseases They Carry     NEWS     Biologists Find Gene That Could Stop Tumors in Their Tracks     NEWS     Medtronic Begins Study of First Predictive Low Glucose Management Technology   Weldable, Sealable BioPharma Tubing - Get a Sample AdvantaFlex® TPE tubing welds, seals and molds into fittings to reduce leaks. No silicone oils or animal derived components; fewer extractables than other tubing. Made in USA. COMPLIMENTARY SAMPLE FEATURED STORY Rare Genetic Disease Protects Against Bipolar Disorder A team of scientists led by researchers at the UMass Medical School and UMMSM have identified what is likely a key genetic pathway underlying bipolar disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders. Read more... Share FULL STORY Versatile Evaporator for Lab & Batch Processing Tasks The Genevac Rocket Synergy Series sets a new benchmark in evaporation versatility. The system is able to dry or concentrate up to six 450ml flasks, or 18 ASE® vials, and with a simple rotor switch enable unattended automated batch processing of up to 100 litres per run. FURTHER INFO NEWS Combating Bladder Cancer With Approved Drug A drug that activates targets of the hedgehog signaling pathway, which is lost when bladder cancer invades, could prevent the progression of the disease in humans. Clinical trials are planned. Read more...                   FULL STORY NEWS Astellas Collaborates with Harvard for Retinal Degeneration Treatment Astellas Pharma Inc. announced a research collaboration with an investigator at Harvard focused on discovering the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic targets. Read more... FULL STORY Biofluid miRNA Profiling: From Sample to Biomarker Join us for a free, educational webcast, as Senior Director of Product Development, Dr. Eric Lader leads an in-depth discussion of: • miRNA Profiling of biofluid samples • miRNA biomarker discovery • supporting data for sample to biomarker miRNA analysis LEARN MORE NEWS Rats of New York and The Diseases They Carry In the first study to look at would-be diseases carried by New York City rats, scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified bacterial pathogens, including E. coli, Salmonella, and C. difficile, that cause mild to life-threatening gastroenteritis in people. Read more... FULL STORY NEWS Biologists Find Gene That Could Stop Tumors in Their Tracks The dirt in your backyard may hold the key to isolating cancerous tumors and to potential new treatments for a host of cancers. Read more...                                          FULL STORY NEWS Medtronic Begins Study of First Predictive Low Glucose Management Technology Medtronic Inc. announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough Predictive Low Glucose Management (PLGM) technology, marking a critical step toward development of an artificial pancreas in the U.S. market. Read more... FULL STORY SUBSCRIBE • UNSUBSCRIBE • ABOUT US • ADVERTISE This email was sent by: Drug Discovery & Development 100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129 We respect your right to privacy - click here to view our policy. ©2014 Drug Discovery & Development. All rights reserved.